Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · August 22, 2021

TNF-α Inhibitors as Steroid-Sparing Monotherapy in CNS Sarcoidosis

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
TNF-α Inhibitors Used as Steroid-Sparing Maintenance Monotherapy in Parenchymal CNS Sarcoidosis
J. Neurol. Neurosurg. Psychiatr. 2021 Jun 08;[EPub Ahead of Print], F Hilezian, A Maarouf, C Boutiere, A Rico, S Demortiere, P Kerschen, T Sene, C Bensa-Koscher, C Giannesini, J Capron, A Mekinian, JP Camdessanché, G Androdias, R Marignier, N Collongues, O Casez, C Coclitu, M Vaillant, G Mathey, J Ciron, J Pelletier, B Audoin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading